Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cumon
- Development stage
- Unknown
- Lead developer
- Niak Pharmaceutical Company
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Cumon is an over-the-counter (OTC) herbal syrup developed by Niak Pharmaceutical Company. It is formulated with a blend of traditional aromatic and carminative herbs, including Zataria multiflora (Shirazi thyme), Carum carvi (black caraway), Foeniculum vulgare (fennel), Pimpinella anisum (aniseed), Mentha longifolia (horsemint), Mentha spicata (spearmint), Boswellia serrata (frankincense), and Trachyspermum ammi (ajwain), sweetened with natural honey. Cumon is primarily indicated for the relief of gastrointestinal symptoms such as bloating, flatulence, nausea, indigestion, and abdominal spasms. The active herbal constituents exert synergistic antispasmodic, anti-inflammatory, and carminative effects, helping to regulate gastrointestinal motility and alleviate abdominal discomfort.
- Brand names
- CumonCumon Syrup
- Other names
- Zataria Niak
Beyond the preview
Go deeper on Cumon.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cumon.